KYTX - Kyverna Therapeutics Inc Revenue Breakdown

Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

Peers: CABA RNAC ARTV AUTL SANA FATE ALLO NKTX ARGX IMVT

| Held by: VTI IWM FESM VXF IWN VTWO IBB KOMP SCHA SURI

Scroll to Statements

Index	RUT
Market Cap	325.91M
Enterprise Value	159.48M
Income	-152.64M
Sales	0.00M
Book/sh	2.69
Cash/sh	3.22
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	130
IPO	Feb 08, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.96
P/C	1.63
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	9.06
Current Ratio	9.06
Debt/Eq	0.20
LT Debt/Eq	0.19
Option/Short	Yes / Yes

EPS (ttm)	-2.94
EPS next Y	-3.12
EPS next Q	-0.69
EPS this Y	24.15%
EPS next Y	-12.84%
EPS next 5Y	10.13%
EPS past 3/5Y	-75.86% -56.27%
Sales past 3/5Y	- -
EPS Y/Y TTM	20.07%
Sales Y/Y TTM	-
EPS Q/Q	35.37%
Sales Q/Q	-
Earnings	Aug 11 AMC
EPS/Sales Surpr.	7.12% -

Insider Own	37.02%
Insider Trans	0.00%
Inst Own	49.09%
Inst Trans	3.66%
ROA	-68.40%
ROE	-87.24%
ROIC	-77.47%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-11.75%
SMA50	-25.36%
SMA200	-35.18%
Trades

Shs Outstand	61.57M
Shs Float	38.95M
Short Float	24.50%
Short Ratio	11.44
Short Interest	9.54M
52W High	13.67 -61.45%
52W Low	5.18 1.74%
Volatility	6.30% 5.82%
ATR (14)	0.36
RSI (14)	30.21
Beta	2.12
Rel Volume	0.73
Avg Volume	834.13K
Volume	100,296

Perf Week	-12.75%
Perf Month	-22.73%
Perf Quarter	-25.46%
Perf Half Y	-39.43%
Perf YTD	-43.94%
Perf Year	-32.52%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	30.40
Prev Close	5.27
Price	5.27
Change %	0.00%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)